Do analysts rate ELOX or ACB?

Eloxx Pharmaceuticals currently has a consensus target price of $38.33, suggesting a potential upside of 139.58%. Given Eloxx Pharmaceuticals' stronger consensus rating and higher probable upside, research analysts plainly believe Eloxx Pharmaceuticals is more favorable than Aurora Cannabis. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Eloxx Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.00 Aurora Cannabis 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.50

Does the media favor ELOX or ACB?

In the previous week, Eloxx Pharmaceuticals had 2 more articles in the media than Aurora Cannabis. MarketBeat recorded 6 mentions for Eloxx Pharmaceuticals and 4 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 0.47 beat Eloxx Pharmaceuticals' score of 0.00 indicating that Aurora Cannabis is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Eloxx Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Aurora Cannabis 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is ZNTL or ELOX more profitable?

Eloxx Pharmaceuticals' return on equity of 0.00% beat Zentalis Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Zentalis Pharmaceuticals N/A -70.18% -51.46% Eloxx Pharmaceuticals N/A N/A N/A

Does the media refer more to ZNTL or ELOX?

In the previous week, Eloxx Pharmaceuticals had 4 more articles in the media than Zentalis Pharmaceuticals. MarketBeat recorded 6 mentions for Eloxx Pharmaceuticals and 2 mentions for Zentalis Pharmaceuticals. Zentalis Pharmaceuticals' average media sentiment score of 0.31 beat Eloxx Pharmaceuticals' score of 0.00 indicating that Zentalis Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zentalis Pharmaceuticals 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Eloxx Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is CRDL or ELOX more profitable?

Eloxx Pharmaceuticals' return on equity of 0.00% beat Cardiol Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Cardiol Therapeutics N/A -180.44% -140.28% Eloxx Pharmaceuticals N/A N/A N/A

Does the media favor CRDL or ELOX?

In the previous week, Eloxx Pharmaceuticals had 1 more articles in the media than Cardiol Therapeutics. MarketBeat recorded 6 mentions for Eloxx Pharmaceuticals and 5 mentions for Cardiol Therapeutics. Cardiol Therapeutics' average media sentiment score of 0.45 beat Eloxx Pharmaceuticals' score of 0.00 indicating that Cardiol Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cardiol Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Eloxx Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend ELOX or SIGA?

Eloxx Pharmaceuticals presently has a consensus price target of $38.33, indicating a potential upside of 139.58%. Given Eloxx Pharmaceuticals' stronger consensus rating and higher possible upside, equities analysts plainly believe Eloxx Pharmaceuticals is more favorable than Siga Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Eloxx Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.00 Siga Technologies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Eloxx Pharmaceuticals (ELOX) Competitors

$16.00 +0.56 (+3.63%)

As of 03:59 PM Eastern

Compare

ELOX vs. AMRN, ACB, ZNTL, CRDL, and SIGA

Should you buy Eloxx Pharmaceuticals stock or one of its competitors? Eloxx Pharmaceuticals's main competitors and comparable companies include Amarin (AMRN), Aurora Cannabis (ACB), Zentalis Pharmaceuticals (ZNTL), Cardiol Therapeutics (CRDL), and Siga Technologies (SIGA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Eloxx Pharmaceuticals compare to Amarin?

Amarin (NASDAQ:AMRN) and Eloxx Pharmaceuticals (NASDAQ:ELOX) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk and earnings.

22.3% of Amarin shares are held by institutional investors. Comparatively, 2.9% of Eloxx Pharmaceuticals shares are held by institutional investors. 4.2% of Amarin shares are held by company insiders. Comparatively, 25.9% of Eloxx Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Eloxx Pharmaceuticals had 5 more articles in the media than Amarin. MarketBeat recorded 6 mentions for Eloxx Pharmaceuticals and 1 mentions for Amarin. Amarin's average media sentiment score of 0.00 equaled Eloxx Pharmaceuticals'average media sentiment score.

Company	Overall Sentiment
Amarin	Neutral
Eloxx Pharmaceuticals	Neutral

Amarin currently has a consensus price target of $13.00, indicating a potential downside of 3.20%. Eloxx Pharmaceuticals has a consensus price target of $38.33, indicating a potential upside of 139.58%. Given Eloxx Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Eloxx Pharmaceuticals is more favorable than Amarin.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Amarin	2 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.33
Eloxx Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00

Eloxx Pharmaceuticals has a net margin of 0.00% compared to Amarin's net margin of -14.56%. Eloxx Pharmaceuticals' return on equity of 0.00% beat Amarin's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Amarin	-14.56%	-0.20%	-0.14%
Eloxx Pharmaceuticals	N/A	N/A	N/A

Amarin has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market. Comparatively, Eloxx Pharmaceuticals has a beta of -1862.26, meaning that its stock price is 186,326% less volatile than the broader market.

Eloxx Pharmaceuticals has lower revenue, but higher earnings than Amarin. Amarin is trading at a lower price-to-earnings ratio than Eloxx Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Amarin	$213.65M	1.33	-$38.80M	-$0.99	N/A
Eloxx Pharmaceuticals	$6.36M	10.16	-$5.99M	-$1.54	N/A

Summary

Eloxx Pharmaceuticals beats Amarin on 12 of the 16 factors compared between the two stocks.

How does Eloxx Pharmaceuticals compare to Aurora Cannabis?

Eloxx Pharmaceuticals (NASDAQ:ELOX) and Aurora Cannabis (NASDAQ:ACB) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment.

Eloxx Pharmaceuticals has a beta of -1862.26, meaning that its share price is 186,326% less volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market.

Eloxx Pharmaceuticals has a net margin of 0.00% compared to Aurora Cannabis' net margin of -32.26%. Aurora Cannabis' return on equity of 4.37% beat Eloxx Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Eloxx Pharmaceuticals	N/A	N/A	N/A
Aurora Cannabis	-32.26%	4.37%	3.45%

Eloxx Pharmaceuticals currently has a consensus target price of $38.33, suggesting a potential upside of 139.58%. Given Eloxx Pharmaceuticals' stronger consensus rating and higher probable upside, research analysts plainly believe Eloxx Pharmaceuticals is more favorable than Aurora Cannabis.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eloxx Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

2.9% of Eloxx Pharmaceuticals shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 25.9% of Eloxx Pharmaceuticals shares are held by insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Eloxx Pharmaceuticals had 2 more articles in the media than Aurora Cannabis. MarketBeat recorded 6 mentions for Eloxx Pharmaceuticals and 4 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 0.47 beat Eloxx Pharmaceuticals' score of 0.00 indicating that Aurora Cannabis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Eloxx Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aurora Cannabis	0 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Eloxx Pharmaceuticals has higher earnings, but lower revenue than Aurora Cannabis. Eloxx Pharmaceuticals is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eloxx Pharmaceuticals	$6.36M	10.16	-$5.99M	-$1.54	N/A
Aurora Cannabis	$247.82M	1.09	-$88.13M	-$1.41	N/A

Summary

Eloxx Pharmaceuticals beats Aurora Cannabis on 9 of the 17 factors compared between the two stocks.

How does Eloxx Pharmaceuticals compare to Zentalis Pharmaceuticals?

Zentalis Pharmaceuticals (NASDAQ:ZNTL) and Eloxx Pharmaceuticals (NASDAQ:ELOX) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

2.9% of Eloxx Pharmaceuticals shares are owned by institutional investors. 3.8% of Zentalis Pharmaceuticals shares are owned by insiders. Comparatively, 25.9% of Eloxx Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Eloxx Pharmaceuticals has lower revenue, but higher earnings than Zentalis Pharmaceuticals. Eloxx Pharmaceuticals is trading at a lower price-to-earnings ratio than Zentalis Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zentalis Pharmaceuticals	$67.43M	2.92	-$137.06M	-$1.95	N/A
Eloxx Pharmaceuticals	$6.36M	10.16	-$5.99M	-$1.54	N/A

Eloxx Pharmaceuticals' return on equity of 0.00% beat Zentalis Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zentalis Pharmaceuticals	N/A	-70.18%	-51.46%
Eloxx Pharmaceuticals	N/A	N/A	N/A

Zentalis Pharmaceuticals has a beta of 1.85, meaning that its stock price is 85% more volatile than the broader market. Comparatively, Eloxx Pharmaceuticals has a beta of -1862.26, meaning that its stock price is 186,326% less volatile than the broader market.

In the previous week, Eloxx Pharmaceuticals had 4 more articles in the media than Zentalis Pharmaceuticals. MarketBeat recorded 6 mentions for Eloxx Pharmaceuticals and 2 mentions for Zentalis Pharmaceuticals. Zentalis Pharmaceuticals' average media sentiment score of 0.31 beat Eloxx Pharmaceuticals' score of 0.00 indicating that Zentalis Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zentalis Pharmaceuticals	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Eloxx Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Zentalis Pharmaceuticals presently has a consensus target price of $6.75, indicating a potential upside of 145.45%. Eloxx Pharmaceuticals has a consensus target price of $38.33, indicating a potential upside of 139.58%. Given Zentalis Pharmaceuticals' higher probable upside, equities analysts plainly believe Zentalis Pharmaceuticals is more favorable than Eloxx Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zentalis Pharmaceuticals	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.40
Eloxx Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00

Summary

Eloxx Pharmaceuticals beats Zentalis Pharmaceuticals on 10 of the 16 factors compared between the two stocks.

How does Eloxx Pharmaceuticals compare to Cardiol Therapeutics?

Cardiol Therapeutics (NASDAQ:CRDL) and Eloxx Pharmaceuticals (NASDAQ:ELOX) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

12.5% of Cardiol Therapeutics shares are owned by institutional investors. Comparatively, 2.9% of Eloxx Pharmaceuticals shares are owned by institutional investors. 5.3% of Cardiol Therapeutics shares are owned by insiders. Comparatively, 25.9% of Eloxx Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Eloxx Pharmaceuticals' return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cardiol Therapeutics	N/A	-180.44%	-140.28%
Eloxx Pharmaceuticals	N/A	N/A	N/A

Cardiol Therapeutics has a beta of 0.79, meaning that its share price is 21% less volatile than the broader market. Comparatively, Eloxx Pharmaceuticals has a beta of -1862.26, meaning that its share price is 186,326% less volatile than the broader market.

In the previous week, Eloxx Pharmaceuticals had 1 more articles in the media than Cardiol Therapeutics. MarketBeat recorded 6 mentions for Eloxx Pharmaceuticals and 5 mentions for Cardiol Therapeutics. Cardiol Therapeutics' average media sentiment score of 0.45 beat Eloxx Pharmaceuticals' score of 0.00 indicating that Cardiol Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cardiol Therapeutics	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Eloxx Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cardiol Therapeutics currently has a consensus price target of $10.00, suggesting a potential upside of 478.03%. Eloxx Pharmaceuticals has a consensus price target of $38.33, suggesting a potential upside of 139.58%. Given Cardiol Therapeutics' higher possible upside, research analysts clearly believe Cardiol Therapeutics is more favorable than Eloxx Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cardiol Therapeutics	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Eloxx Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00

Eloxx Pharmaceuticals has higher revenue and earnings than Cardiol Therapeutics. Eloxx Pharmaceuticals is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cardiol Therapeutics	N/A	N/A	-$24.20M	-$0.25	N/A
Eloxx Pharmaceuticals	$6.36M	10.16	-$5.99M	-$1.54	N/A

Summary

Eloxx Pharmaceuticals beats Cardiol Therapeutics on 8 of the 15 factors compared between the two stocks.

How does Eloxx Pharmaceuticals compare to Siga Technologies?

Eloxx Pharmaceuticals (NASDAQ:ELOX) and Siga Technologies (NASDAQ:SIGA) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, media sentiment, institutional ownership, risk, valuation, profitability and dividends.

In the previous week, Eloxx Pharmaceuticals had 5 more articles in the media than Siga Technologies. MarketBeat recorded 6 mentions for Eloxx Pharmaceuticals and 1 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 0.80 beat Eloxx Pharmaceuticals' score of 0.00 indicating that Siga Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Eloxx Pharmaceuticals	Neutral
Siga Technologies	Positive

Eloxx Pharmaceuticals has a beta of -1862.26, meaning that its share price is 186,326% less volatile than the broader market. Comparatively, Siga Technologies has a beta of 0.97, meaning that its share price is 3% less volatile than the broader market.

Eloxx Pharmaceuticals presently has a consensus price target of $38.33, indicating a potential upside of 139.58%. Given Eloxx Pharmaceuticals' stronger consensus rating and higher possible upside, equities analysts plainly believe Eloxx Pharmaceuticals is more favorable than Siga Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Eloxx Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00
Siga Technologies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Siga Technologies has higher revenue and earnings than Eloxx Pharmaceuticals. Siga Technologies is trading at a lower price-to-earnings ratio than Eloxx Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Eloxx Pharmaceuticals	$6.36M	10.16	-$5.99M	-$1.54	N/A
Siga Technologies	$94.57M	2.47	$23.28M	-$0.05	N/A

2.9% of Eloxx Pharmaceuticals shares are owned by institutional investors. Comparatively, 55.4% of Siga Technologies shares are owned by institutional investors. 25.9% of Eloxx Pharmaceuticals shares are owned by insiders. Comparatively, 2.7% of Siga Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Eloxx Pharmaceuticals has a net margin of 0.00% compared to Siga Technologies' net margin of -5.19%. Eloxx Pharmaceuticals' return on equity of 0.00% beat Siga Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Eloxx Pharmaceuticals	N/A	N/A	N/A
Siga Technologies	-5.19%	-1.55%	-1.32%

Summary

Eloxx Pharmaceuticals beats Siga Technologies on 11 of the 17 factors compared between the two stocks.

Get Eloxx Pharmaceuticals News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ELOX vs. The Competition

Export

Metric	Eloxx Pharmaceuticals	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$67.53M	$12.66B	$7.33B	$13.29B
Dividend Yield	N/A	2.62%	2.52%	12.57%
P/E Ratio	-10.39	789.89	274.40	25.75
Price / Sales	10.16	810.08	639.66	87.10
Price / Cash	N/A	88.64	77.80	52.76
Price / Book	-0.19	10.69	10.52	6.34
Net Income	-$5.99M	$2.83B	$3.49B	$360.00M
7 Day Performance	-8.83%	-0.69%	-1.08%	-0.11%
1 Month Performance	-19.96%	-1.10%	-3.39%	-3.42%
1 Year Performance	N/A	2.10%	15.08%	5.46%

Eloxx Pharmaceuticals Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ELOX Eloxx Pharmaceuticals	2.4185 of 5 stars	$16.00 +3.6%	$38.33 +139.6%	N/A	$67.53M	$6.36M	N/A	7	Short Interest Increase Gap Up
AMRN Amarin	0.4434 of 5 stars	$13.84 -0.6%	$13.00 -6.1%	-10.7%	$294.24M	$213.65M	N/A	80
ACB Aurora Cannabis	1.0694 of 5 stars	$3.83 +0.3%	N/A	-16.1%	$247.70M	$247.82M	N/A	1,028	News Coverage Gap Down
ZNTL Zentalis Pharmaceuticals	3.5135 of 5 stars	$3.10 -1.0%	$6.75 +117.7%	+91.3%	$224.33M	$67.43M	N/A	106
CRDL Cardiol Therapeutics	2.7241 of 5 stars	$1.90 +2.7%	$10.00 +426.3%	+62.4%	$214.93M	N/A	N/A	18	News Coverage Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ELOX) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Eloxx Pharmaceuticals (ELOX) Competitors

ELOX vs. AMRN, ACB, ZNTL, CRDL, and SIGA

How does Eloxx Pharmaceuticals compare to Amarin?

Summary

How does Eloxx Pharmaceuticals compare to Aurora Cannabis?

Summary

How does Eloxx Pharmaceuticals compare to Zentalis Pharmaceuticals?

Summary

How does Eloxx Pharmaceuticals compare to Cardiol Therapeutics?

Summary

How does Eloxx Pharmaceuticals compare to Siga Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELOX vs. The Competition

Eloxx Pharmaceuticals Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Eloxx Pharmaceuticals (ELOX) Competitors

ELOX vs. AMRN, ACB, ZNTL, CRDL, and SIGA

How does Eloxx Pharmaceuticals compare to Amarin?

Do insiders & institutionals believe in AMRN or ELOX?

Does the media favor AMRN or ELOX?

Do analysts recommend AMRN or ELOX?

Is AMRN or ELOX more profitable?

Which has more volatility and risk, AMRN or ELOX?

Which has stronger valuation and earnings, AMRN or ELOX?

Summary

How does Eloxx Pharmaceuticals compare to Aurora Cannabis?

Which has more volatility and risk, ELOX or ACB?

Is ELOX or ACB more profitable?

Do analysts rate ELOX or ACB?

Do insiders and institutionals hold more shares of ELOX or ACB?

Does the media favor ELOX or ACB?

Which has stronger earnings and valuation, ELOX or ACB?

Summary

How does Eloxx Pharmaceuticals compare to Zentalis Pharmaceuticals?

Do institutionals and insiders believe in ZNTL or ELOX?

Which has preferable valuation and earnings, ZNTL or ELOX?

Is ZNTL or ELOX more profitable?

Which has more volatility and risk, ZNTL or ELOX?

Does the media refer more to ZNTL or ELOX?

Do analysts prefer ZNTL or ELOX?

Summary

How does Eloxx Pharmaceuticals compare to Cardiol Therapeutics?

Do institutionals & insiders hold more shares of CRDL or ELOX?

Is CRDL or ELOX more profitable?

Which has more risk and volatility, CRDL or ELOX?

Does the media favor CRDL or ELOX?

Do analysts recommend CRDL or ELOX?

Which has preferable valuation and earnings, CRDL or ELOX?

Summary

How does Eloxx Pharmaceuticals compare to Siga Technologies?

Does the media prefer ELOX or SIGA?

Which has more risk & volatility, ELOX or SIGA?

Do analysts recommend ELOX or SIGA?

Which has preferable earnings & valuation, ELOX or SIGA?

Do insiders & institutionals believe in ELOX or SIGA?

Is ELOX or SIGA more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ELOX vs. The Competition

Eloxx Pharmaceuticals Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools